Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

2.24
Delayed Data
As of Jan 20
 +0.01 / +0.45%
Today’s Change
2.19
Today|||52-Week Range
4.33
-12.16%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +234.82% increase from the last price of 2.24.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$0.00
Reporting Date
Feb 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -23.81%
 
 
 
 
 
 
Growthannually -3.57%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually 12.86%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.